Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.

cumulative incidence of second primary cutaneous squamous cell carcinoma tumors and safety. Researchers performed the first prespecified interim analysis after median follow-up of 24 months (range ...

Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) and its oncology-focused subsidiary, Citius ...

Medically reviewed by Oliver Eng, MD Itchy skin, or pruritus, can be a symptom of some cancers, including blood-related, skin, liver, gallbladder, and bile-duct cancer cancers. However, other causes ...